Intramedullary Nails Market Expected to Reach $1.7 Billion by 2032

According to a new report published by Allied Market Research, titled, “Intramedullary Nails Market," The intramedullary nails market size was valued at $1 billion in 2022, and is estimated to reach $1.7 billion by 2032, growing at a CAGR of 5.6% from 2023 to 2032.

An intramedullary nail is a medical device used in orthopedic surgery for the treatment of fractures, particularly long bone fractures such as those in the femur or tibia. Also known as an intramedullary rod or nail, it is a metal implant inserted into the medullary canal (the central cavity) of a long bone to stabilize and support the bone during the healing process.                       

As the global population ages and lifestyles change, the incidence of fractures, particularly long bone fractures, is on the rise. Factors such as accidents, sports injuries, and osteoporosis contribute to this trend, resulting in a higher demand for orthopedic implants like intramedullary nails. Ongoing advancements in implant design, materials, and surgical techniques improve the efficacy and outcomes of intramedullary nail procedures.

Innovations such as locking mechanisms, biodegradable implants, and minimally invasive approaches drive market growth by enhancing implant performance, reducing surgical complications, and facilitating faster recovery times. Participation in sports and physical activities, as well as the risk of trauma-related injuries from accidents, contributes to the demand for orthopedic implants. Athletes and individuals with active lifestyles may require surgical intervention for long bone fractures, leading to increased utilization of intramedullary nails. These factors are anticipated to drive the intramedullary nails market growth in the upcoming years.

However, in some cases, fractures treated with intramedullary nails may fail to heal properly, resulting in non-union (failure of the bone ends to unite) or delayed union (prolonged healing time). Factors such as poor bone quality, inadequate blood supply, and improper surgical technique can contribute to these complications. Any surgical procedure carries a risk of infection, and intramedullary nailing is no exception. Despite efforts to maintain sterile conditions during surgery, there is still a risk of introducing bacteria into the surgical site, which can lead to postoperative infections.These factors are anticipated to restraint the intramedullary nails market size.

Continuous innovation in implant design, materials, and manufacturing processes presents a significant opportunity within the intramedullary nail market. Companies investing in R&D can introduce implants with enhanced biomechanical properties, improved fixation mechanisms, and advanced coatings to promote osseointegration, leading to better patient outcomes and surgeon satisfaction. The increasing elderly population globally presents a substantial opportunity for the intramedullary nail market players. As senior adults are more susceptible to fractures due to age-related conditions such as osteoporosis, there is a rising demand for orthopedic implants like intramedullary nails for fracture fixation in this demographic segment. These factors are anticipated to drive the intramedullary nails market opportunity in the upcoming years.

The intramedullary nails market share is segmented on the basis of product type, material, application, end user, and region. By product type, it is classified into upper bone extremities and lower bone extremities. By material, it is classified into stainless steel and titanium. By application, it is classified into femoral intramedullary nail, tibial intramedullary nail, gamma intramedullary nail, and others. By end user, it is classified into hospitals, specialty clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the intramedullary nails market analysis report include Stryker, B. Braun Melsungen AG, Zimmer Biomet, Smith+Nephew, Johnson & Johnson, Orthopaedic Implant Company, Orthofix Holdings, Inc., Wright Medical Group N.V., Advanced Orthopaedic Solutions, and Aysam Ortopedi & Tibbi Cihazlar.

The report offers a comprehensive analysis of the global intramedullary nails market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also highlights on the present scenario and upcoming trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the intramedullary nails industry.

Key Findings of the Study

• Based on product type, the upper bone extremities sub-segment emerged as the global leader in 2022 and the lower bone extremities sub-segment is anticipated to be the fastest growing during the intramedullary nails market forecast period.
• Based on material, the titanium sub-segment emerged as the global leader in 2022 and is predicted to show the fastest growth in the upcoming years.
• Based on application, the femoral intramedullary nail sub-segment emerged as the global leader in 2022 and is predicted to show the fastest growth in the upcoming years.
• Based on end user, the hospitals sub-segment emerged as the global leader in 2022 and is predicted to show the fastest growth in the intramedullary nails industry upcoming years.
• Based on region, North America registered the highest intramedullary nails market share share in 2022 and is projected to maintain its position during the forecast period.